Palobiofarma S.L.
PrivateLast Round
Series C
Feb 2, 2024
Total Funding Raised
$9.62M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Palobiofarma S.L. operates in Healthcare & Life Sciences and is based in Mataró. Its latest recorded funding round was a Series C round in February 2024.
Palobiofarma S.L. is a biopharmaceutical company that discovers and develops innovative drugs based on the modulation of adenosine receptors for the treatment of cancer and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Palobiofarma S.L. Comparables
Compare Palobiofarma S.L. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innolake Biopharm | 80% | |
| Medibiofarma | 80% | |
| Kainova Therapeutics | 79% |
For institutional investors. Book with your work email.
Palobiofarma S.L. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 2, 2024 | ||||
| Series B | Sep 26, 2019 | ||||
| VC Round | Jun 20, 2013 | ||||
| VC Round | May 1, 2012 | ||||
| Seed | Jun 28, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Palobiofarma S.L. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation for Prader-Willi Research | Series C |
| Inveready | Series C |
| Fitalent | VC Round |
| Sodena | VC Round, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 68% MoM.
- Jun 22, 2026
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 26, 2026
Palobiofarma's COO presents Phase 2 PBF-999 results at the FPWR Research Symposium in Pennsylvania on Oct 8th '26.
For institutional investors. Book with your work email.
Palobiofarma S.L. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Palobiofarma S.L.'s valuation, stock price, and market status.
Is Palobiofarma S.L. a public or private company?
Palobiofarma S.L. is a private company.
What is the current stock price of Palobiofarma S.L.?
Palobiofarma S.L. is a private company, so its shares have no public market price. Caplight tracks Palobiofarma S.L.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Palobiofarma S.L. worth (valuation)?
Valuation information for Palobiofarma S.L. is not publicly available.
Can I buy Palobiofarma S.L. stock?
Palobiofarma S.L. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Palobiofarma S.L.'s last funding round?
Palobiofarma S.L.'s most recent funding round was Series C on February 2, 2024.
Who are the main investors in Palobiofarma S.L.?
Key investors in Palobiofarma S.L. include Inveready, Sodena.
Will Palobiofarma S.L. IPO soon?
No public IPO plans have been announced for Palobiofarma S.L..
How can I track Palobiofarma S.L. secondary market activity?
Caplight tracks bids, offers, and trades in Palobiofarma S.L.'s shares on secondary markets.